• Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101 | Morningstar

    ソース: Buzz FX / 13 12 2024 00:41:20   America/New_York


    Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101
    Accropeutics Inc. Announces U.S. FDA Clearance of IND Application for RIPK2 Inhibitor AC-101
    PR Newswire
    NEW YORK and SUZHOU, China, Dec.
    Read more...
シェアする